BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8217119)

  • 1. Transmissible spongiform encephalopathies and the safety of naturally-derived biologicals.
    Di Martino A
    Biologicals; 1993 Mar; 21(1):61-6. PubMed ID: 8217119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prion hypothesis and the human prion diseases].
    Aguzzi A
    Berl Munch Tierarztl Wochenschr; 2002; 115(3-4):91-8. PubMed ID: 11938572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transmissible spongiform encephalopathies in animals].
    Fatzer R; Vandevelde M
    Wien Med Wochenschr; 1998; 148(4):78-85. PubMed ID: 9611347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine sera used in the manufacture of biologicals: current concerns and policies of the U.S. Food and Drug Administration regarding the transmissible spongiform encephalopathies.
    Asher DM
    Dev Biol Stand; 1999; 99():41-4. PubMed ID: 10404874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part I].
    Zaborowski A
    Psychiatr Pol; 2004; 38(2):283-96. PubMed ID: 15307293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transmissible spongiform encephalopathies--anesthesiologic and intensive care management].
    Menges T; Langefeld TW; Krumholz W; Hempelmann G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Feb; 36(2):79-89. PubMed ID: 11269018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Spongiform encephalopathies].
    Pastoret PP
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):25-38. PubMed ID: 9868830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.
    Priola SA; Vorberg I
    Methods Mol Biol; 2004; 268():517-40. PubMed ID: 15156065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmissible spongiform encephalopathies.
    Sejvar JJ; Schonberger LB; Belay ED
    J Am Vet Med Assoc; 2008 Dec; 233(11):1705-12. PubMed ID: 19046027
    [No Abstract]   [Full Text] [Related]  

  • 10. BSE: can we predict the future?
    Plum J
    Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transmissible spongiform encephalopathy].
    Koukolík F
    Cas Lek Cesk; 1998 Apr; 137(8):227-30. PubMed ID: 9650345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmissible spongiform encephalopathies and human neurodegenerative disease.
    Esmonde TF; Will RG
    Br J Hosp Med; 1993 Mar 17-Apr 6; 49(6):400-4, 406. PubMed ID: 8472098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostics for TSE agents.
    Raeber AJ; Oesch B
    Dev Biol (Basel); 2006; 123():313-23; discussion 349-54. PubMed ID: 16566455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transmissible spongiform encephalopathies].
    Vujosević M
    Srp Arh Celok Lek; 1997; 125(7-8):234-43. PubMed ID: 9304238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prion disease as infectious disease transmissible from animals to human].
    Horiuchi M
    Nihon Rinsho; 2005 Dec; 63(12):2213-20. PubMed ID: 16363697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basic research on BSE transmission to people].
    Bodemer W; Kaup FJ
    Dtsch Tierarztl Wochenschr; 2002 Aug; 109(8):338-41. PubMed ID: 12224460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human prion diseases. A review with special emphasis on new variant CJD and comments on surveillance.
    Keohane C
    Clin Exp Pathol; 1999; 47(3-4):125-32. PubMed ID: 10472732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of biological products prepared from mammalian cell culture. Bovine spongiform encephalopathy and other non-viral transmissible agents.
    Dev Biol Stand; 1998; 93():133-4. PubMed ID: 9737391
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bovine spongiform encephalopathy in ruminants and the new variant of Creutzfeldt-Jakob disease in humans].
    Groschup MH
    Dtsch Tierarztl Wochenschr; 1999 Aug; 106(8):329-31. PubMed ID: 10488637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Note for guidance. Guidelines for minimizing the risk of transmitting agents causing spongiform encephalopathy via medicinal products. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
    Biologicals; 1992 Jun; 20(2):155-8. PubMed ID: 1389111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.